Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Organigram Global Inc.NASDAQ: OGI

Operating Margin · Q2 FY2026 · quarter ended Mar 2026

Operating margin narrows to -16.4%

Operating margin was -16.4% in Q2 FY2026, down 4.8 pp from a year earlier. On a trailing-twelve-month basis it was -5.2%, up 4.7 pp year over year.

Context

  • Operating margin widened in 1 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 3 analysts of 21.8% for the fiscal year ending Sep 2026, up from -34.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-16.4%-11.0 pp QoQ
Last fiscal yearSep 2025
-34.1%-11.8 pp YoY
LTMMar 2026
-5.2%+4.7 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.8 pp+2.5 pp+7.4 pp
1 year-11.8 pp+55.9 pp+67.6 pp
3 years—+37.2 pp—
5 years+38.5 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-34.1%
Year-over-year change
-11.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How OGI compares with its peers on the latest reported figures

  • OGI's LTM Mar 2026 operating margin of -5.2% is the 5th highest of the 10 companies compared; the peer median is -9.8%.
  • Its year-over-year change of +4.7 pp is the 3rd highest of 9, against a peer median of +2.7 pp.
OGI Competitors Peer median
Operating Margin for OGI and competitors
Company Period LTM level YoY 3-year change
ELMDElectromed, Inc.LTM Mar 202618.5% +4.0 pp+8.3 pp
INFUInfuSystem Holdings, Inc.LTM Mar 20269.1% +3.0 pp+6.8 pp
ACBAurora Cannabis Inc.LTM Mar 20260.3% -1.2 pp+41.8 pp
LFCRLifecore Biomedical, Inc.LTM Mar 2026-0.1% —-2.8 pp
OGIOrganigram Global Inc.LTM Mar 2026-5.2% +4.7 pp—
DERMJourney Medical CorporationLTM Mar 2026-9.8% +2.5 pp+24.1 pp
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026-168.0% +2215.9 pp+769.6 pp
HSDTSolana CompanyLTM Mar 2026-196.6% +3143.9 pp+1620.5 pp
IVAInventiva S.A.FY2025-2921.0% -1860.3 pp-2452.0 pp
RNACCartesian Therapeutics, Inc.LTM Mar 2026-5144.5% -4991.1 pp-3113.1 pp
Peer median (excluding OGI) -9.8%+2.7 pp+8.3 pp

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.